Literature DB >> 30126540

Persistence/recurrence of and remission from DSM-5 substance use disorders in the United States: Substance-specific and substance-aggregated correlates.

Sean Esteban McCabe1, Brady T West2, Stephen Strobbe3, Carol J Boyd4.   

Abstract

This study examined demographic and psychosocial correlates associated with persistence/recurrence of and remission from at least one of ten DSM-5 substance use disorders (SUDs) and three substance-specific SUDs (i.e., alcohol, cannabis, and prescription opioids). Data were collected from structured diagnostic interviews and national prevalence estimates were derived from the 2012-2013 National Epidemiologic Survey on Alcohol and Related Conditions. An estimated 25.4% of the U.S. population had at least one prior-to-past-year (prior) SUD. Among individuals with any prior SUDs, the prevalence of past-year substance use and DSM-5 symptomology was as follows: abstinence (14.2%), asymptomatic use (36.9%), symptomatic use (10.9%), and persistent/recurrent SUD (38.1%). Among individuals with prior SUDs, design-based multinomial logistic regression analysis revealed that young adulthood, higher educational attainment, higher personal income, never having been married, being divorced/separated/widowed, lack of lifetime substance use treatment, and stressful life events predicted significantly greater odds of past-year persistent/recurrent SUDs, relative to abstinence. In addition, remission from a prior tobacco use disorder decreased the probability of past-year persistent/recurrent SUD, relative to abstinence. Stressful life events were the only common correlates across the aggregation of all SUDs and each substance-specific SUD, but differences were found for specific stressful life events between drug classes. Nearly half (49%) of adults with prior DSM-5 SUDs continued to report past-year symptomatic substance use, while only one in seven individuals were abstinent. The findings suggest the value of examining remission associated with both substance-specific SUDs and aggregation of SUDs based on the shared and unique correlates of persistent/recurrent SUDs; this is especially true for stressful life events, which could be useful targets for enhancing clinical care and interventions.
Copyright © 2018 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Abstinence; DSM-5; Remission; Stress; Substance use disorders

Mesh:

Year:  2018        PMID: 30126540      PMCID: PMC6237097          DOI: 10.1016/j.jsat.2018.07.012

Source DB:  PubMed          Journal:  J Subst Abuse Treat        ISSN: 0740-5472


  36 in total

1.  Changes in the prevalence of non-medical prescription drug use and drug use disorders in the United States: 1991-1992 and 2001-2002.

Authors:  Carlos Blanco; Donald Alderson; Elizabeth Ogburn; Bridget F Grant; Edward V Nunes; Mark L Hatzenbuehler; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2007-05-21       Impact factor: 4.492

2.  Sexual orientation and substance abuse treatment utilization in the United States: results from a national survey.

Authors:  Sean Esteban McCabe; Brady T West; Tonda L Hughes; Carol J Boyd
Journal:  J Subst Abuse Treat       Date:  2012-03-22

3.  Changes in cigarette consumption and drinking outcomes: findings from Project MATCH.

Authors:  Karen B Friend; Maria E Pagano
Journal:  J Subst Abuse Treat       Date:  2005-10

4.  The effect of inmate populations on estimates of DSM-IV alcohol and drug use disorders in the United States.

Authors:  Wilson M Compton; Deborah Dawson; Sarah Q Duffy; Bridget F Grant
Journal:  Am J Psychiatry       Date:  2010-04       Impact factor: 18.112

5.  Prevalence, sociodemographic correlates and DSM-5 substance use disorders and other psychiatric disorders among sexual minorities in the United States.

Authors:  Bradley T Kerridge; Roger P Pickering; Tulshi D Saha; W June Ruan; S Patricia Chou; Haitao Zhang; Jeesun Jung; Deborah S Hasin
Journal:  Drug Alcohol Depend       Date:  2016-11-07       Impact factor: 4.492

6.  Victimization and substance use disorders in a national sample of heterosexual and sexual minority women and men.

Authors:  Tonda Hughes; Sean Esteban McCabe; Sharon C Wilsnack; Brady T West; Carol J Boyd
Journal:  Addiction       Date:  2010-09-15       Impact factor: 6.526

7.  Initial reliability and validity of a new retrospective measure of child abuse and neglect.

Authors:  D P Bernstein; L Fink; L Handelsman; J Foote; M Lovejoy; K Wenzel; E Sapareto; J Ruggiero
Journal:  Am J Psychiatry       Date:  1994-08       Impact factor: 18.112

8.  Prevalence, correlates, disability, and comorbidity of DSM-IV drug abuse and dependence in the United States: results from the national epidemiologic survey on alcohol and related conditions.

Authors:  Wilson M Compton; Yonette F Thomas; Frederick S Stinson; Bridget F Grant
Journal:  Arch Gen Psychiatry       Date:  2007-05

9.  The sexual abuse of Afro-American and white-American women in childhood.

Authors:  G E Wyatt
Journal:  Child Abuse Negl       Date:  1985

10.  Epidemiology of DSM-5 Drug Use Disorder: Results From the National Epidemiologic Survey on Alcohol and Related Conditions-III.

Authors:  Bridget F Grant; Tulshi D Saha; W June Ruan; Risë B Goldstein; S Patricia Chou; Jeesun Jung; Haitao Zhang; Sharon M Smith; Roger P Pickering; Boji Huang; Deborah S Hasin
Journal:  JAMA Psychiatry       Date:  2016-01       Impact factor: 21.596

View more
  3 in total

Review 1.  Therapeutic efficacy of environmental enrichment for substance use disorders.

Authors:  Ewa Galaj; Eddy D Barrera; Robert Ranaldi
Journal:  Pharmacol Biochem Behav       Date:  2019-11-26       Impact factor: 3.533

2.  Investigating differential protective effects of marriage on substance use by sexual identity status.

Authors:  Karen F Trocki; Amy A Mericle; Laurie A Drabble; Jamie L Klinger; Cindy B Veldhuis; Tonda L Hughes; Katherine J Karriker-Jaffe
Journal:  Int J Alcohol Drug Res       Date:  2020-10-19

3.  BDNF and Cortisol in the Diagnosis of Cocaine-Induced Depression.

Authors:  Francina Fonseca; Joan Ignasi Mestre-Pinto; Rocío Rodríguez-Minguela; Esther Papaseit; Clara Pérez-Mañá; Klaus Langohr; Margherita Barbuti; Magí Farré; Marta Torrens
Journal:  Front Psychiatry       Date:  2022-03-15       Impact factor: 4.157

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.